These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6238245)

  • 1. Elevation of gamma-aminobutyric acid in human brain may increase dopaminergic neuronal function.
    Perry TL; Ito M; Jones K; Hansen S
    Neurosci Lett; 1984 Sep; 50(1-3):67-71. PubMed ID: 6238245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid effects on choreiform movement and on GABA, HVA, and 5-HIAA in CSF.
    Yamamoto M; Otsuki S; Kuroda H; Ogawa N
    Acta Neurol Scand; 1983 Feb; 67(2):124-7. PubMed ID: 6189358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemistry of dopamine in Huntington's dementia and normal aging.
    Stahl SM; Thiemann S; Faull KF; Barchas JD; Berger PA
    Arch Gen Psychiatry; 1986 Feb; 43(2):161-4. PubMed ID: 2936315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid therapy of Huntington disease.
    Perry TL; Wright JM; Hansen S; MacLeod PM
    Neurology; 1979 Mar; 29(3):370-5. PubMed ID: 156313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF homovanillic acid: an index of dopaminergic activity.
    Curzon G
    Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 11. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
    Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
    Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.
    Espino A; Llorens J; Calopa M; Bartrons R; Rodriguez-Farré E; Ambrosio S
    Brain Res; 1995 Jan; 669(1):19-25. PubMed ID: 7712161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
    Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
    Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homovanillic acid (HVA) and gamma-aminobutyric acid (GABA) levels in the cerebrospinal fluid of patients with extrapyramidal syndromes].
    Smiałek M; Królikiewicz-Sciborowska H; Skrobisz MD; Niemczewska-Syropolska M; Sasinowska M
    Neuropatol Pol; 1986; 24(4):585-602. PubMed ID: 3587659
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gamma-aminobutyric acid (GABA) and homovanillic acid (HVA) levels in the cerebrospinal fluid of patients with epilepsy].
    Klimowicz-Młodzik I; Pisarski W; Sasinowska M; Smiałek M
    Neuropatol Pol; 1985; 23(3):419-32. PubMed ID: 4088467
    [No Abstract]   [Full Text] [Related]  

  • 16. Bromocriptine and dopaminergic function in Huntington disease.
    Loeb C; Roccatagliata G; Albano C; Besio G
    Neurology; 1979 May; 29(5):730-4. PubMed ID: 155784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in postmortem tissues and in rats with kainic acid lesions.
    Melamed E; Hefti F; Bird ED
    Neurology; 1982 Jun; 32(6):640-4. PubMed ID: 6211637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
    Tell G; Böhlen P; Schechter PJ; Koch-Weser J; Agid Y; Bonnet AM; Coquillat G; Chazot G; Fischer C
    Neurology; 1981 Feb; 31(2):207-11. PubMed ID: 6258106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
    Stanley M; Traskman-Bendz L; Dorovini-Zis K
    Life Sci; 1985 Oct; 37(14):1279-86. PubMed ID: 2413327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.